ARHS Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
ARHS is not a good buy right now for a Beginner investor focused on long-term holding. The stock has some constructive fundamental signs from Q1 revenue growth and a slight earnings beat, but the technical trend is bearish, analyst sentiment has been drifting lower, and the latest options flow does not show a strong bullish setup. Given the current weakness and lack of a clear proprietary buy signal, I would not buy it now. The better call is to wait.
ARHS is in a weak technical position. The MACD histogram is negative and worsening, RSI_6 at 39.7 is neutral-to-weak, and the moving averages are bearish with SMA_200 > SMA_20 > SMA_5, which confirms a downtrend. Price at 7.075 is below the pivot at 7.33 and close to support at 6.953, so momentum is poor and the chart does not support an immediate long-term entry.
Arhaus reported record Q1 revenue of $314 million, up 0.9% year over year, and Q1 GAAP EPS of $0.02 above expectations. The company also remains positioned to benefit if housing demand improves and showroom expansion continues to support share gains over time.
Recent analyst actions show repeated price target cuts across several firms, reflecting softer demand and lower confidence in near-term recovery. News and analyst commentary point to choppy demand, unfavorable weather, the Iran conflict, promotional pressure, weak housing turnover, and margin strain from investments. Financially, gross margin declined to 36.41% and net income dropped to zero in the latest quarter, which weakens the long-term quality of the beat.
In Q1 2026, Arhaus posted revenue of $314.28 million, up 0.93% year over year, which is modest growth. However, net income fell to 0, EPS declined to 0.02 from 0.03, and gross margin slipped to 36.41% from 38.32%. This was a revenue beat, but profitability trends were weaker, so the quarter was mixed rather than strong.
Analyst sentiment has become more cautious recently. Telsey cut its target to $9 from $11 and kept Market Perform, Jefferies cut to $7.25 from $9.50 and kept Hold, BofA cut to $11 from $12 and kept Neutral, and Morgan Stanley trimmed to $10.50 from $12 and kept Equal Weight. TD Cowen is still positive with a Buy rating, but even it lowered its target to $9 from $12. The Wall Street view is therefore mixed-to-cautious, with more emphasis on near-term demand weakness than upside.
